Lonza buys Vivante to expand custom biologics biz
Lonza buys viral-based biologics maker Vivante GMP Solutions to broaden custom manufacturing offering.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Lonza buys viral-based biologics maker Vivante GMP Solutions to broaden custom manufacturing offering.